DAVA Mission Statement
To improve patient care by realizing the full potential of oncology drug development.
DAVA Oncology was founded in 2007 with a mission to facilitate successful drug development. During our quest, we have created innovative solutions and services that have accelerated the clinical development process. We strive to meet your unmet needs through knowledge-based strategic consulting, accrual enhancement initiatives and medical oncology support.
DAVA Oncology is led by a team of highly experienced senior managers, who have been integral to the Company’s success. Their commitment to quality, innovation and talent recruitment is unparalleled and this team is capable and eager to manage the organization through sustained, rapid growth in the future. The Company’s senior management team brings a wealth of broad medical, scientific and business experience, with an average of over 20 years in the biopharmaceutical, clinical medicine and drug development industries.
Strategic Consulting: DAVA’s evidence-based strategic insight will provide you with tools to make intelligent decisions during development of your molecule. We offer many products and services customized to fit your drug development needs...
Trial Acceleration: DAVA's dedicated medical oncology team can make timely clinical trial completion a reality. Whether you need enrollment planning, targeted investigator and referral outreach, site assessment or protocol feasibility analysis, DAVA has the tools you need to succeed...
Since 2007, DAVA Oncology has worked with 43 biopharmaceutical companies on over 260 projects. These include large and mid-sized pharmaceutical companies as well as large, medium and small biotech companies (figure below). DAVA has provided services for 16 of the top 20 pharma and biotech companies.
“Our business relation started by sharing goals and developing a sense of shared purpose, but most importantly, it is built on a foundation of trust. When operational difficulties arise, DAVA’s can-do attitude reveals itself as true commitment.”
- Long-term pharmaceutical client
“Very good. Very informative. Excellent organization. Good discussions. Excellent perspective globally on rationale, challenges, and progress of study. Outstanding meeting.”
- Accrual Workshops attendee
DAVA Oncology Sign Agreement to Boost Patient Participation in Clinical Trials...
DAVA Oncology, LP will participate in the upcoming DIA meeting June 24- 28, 2012 in Philadelphia, PA...
Dallas, TX – DAVA Oncology, LP is pleased to announce the addition of Alex Denes, MD as a member of the medical oncology…
DAVA Oncology, LP will participate in the upcoming SCOPE meeting in Miami Florida on February 7-9, 2012…